The founder and chairman of C-Levelclone, a management company, who is a longtime Arlington resident, explained: “CryoMedic Technologies is the name we use for the patent technology and then license it to C-Levelclone LLC.”
His company website says: “CryoMedic Technologies currently has a patent pending which utilizes a unique variable heat transfer technique that addresses both freezing at -196°C and thawing at ambient room temperature. A plastic bag material, the CryoBlood Pak® (FDA approved) is used to contain the blood during the process. There is also a patent pending fabrication technique for the container bag.”
Walker provided an update: “We are introducing this technology to Italy, England, Africa and Dubai as well as others.” His technology has been recognized by the Association for the Advancement of Blood & Biotherapies, formerly the American Academy of Blood Banking.
Learn more from a recent interview with Good News Planet.
In the 22-minute video are, clockwise from top left,Sunil M. Upadhye, an investment broker; Paul Sladkus, a veteran television executive; Walker and Dr. Ted Robinson, a surgeon who is part of C-Levelclone’s medical advisory board.
Investors, please note: The basic research has been completed. Continuing clinical testing is in process.
Those interested should contact Walker at 617-799-4211 or jwalker at c-levelclone.com for more information.
Oct. 9, 2018: LONG-LASTING BLOOD: Arlington entrepreneur seeks funding for cryopreservation
This news summary was published Saturday, Jan. 1, 2022.
